Full Press Release Details
Solid Biosciences Announces FDA IND Clearance for First In Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich s At.
SLDB
Solid Biosciences Announces FDA IND Clearance for First In Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich s At
Key Takeaway: Solid Biosciences Announces FDA IND Clearance for First In Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich s At